Retention in HIV care between testing and treatment in sub-Saharan Africa: A systematic review

PLoS Medicine

Volumn 8, Issue 7, 2011, Pages

  Rosen, Sydney ^a,b   Fox, Matthew P ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AFRICA; ANTIVIRAL THERAPY; CD4 LYMPHOCYTE COUNT; DISEASE SEVERITY; DRUG INDICATION; HEALTH CARE; HEALTH PROGRAM; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; OUTCOME ASSESSMENT; OUTCOMES RESEARCH; RETENTION IN CARE; REVIEW; SYSTEMATIC REVIEW; VIRUS DIAGNOSIS; AFRICA SOUTH OF THE SAHARA; CD4+ T LYMPHOCYTE; CYTOLOGY; DEVELOPING COUNTRY; HEALTH SERVICE; PATIENT COMPLIANCE; TIME; TREATMENT OUTCOME; TREATMENT REFUSAL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AFRICA SOUTH OF THE SAHARA; ANTI-HIV AGENTS; CD4-POSITIVE T-LYMPHOCYTES; DEVELOPING COUNTRIES; HEALTH SERVICES NEEDS AND DEMAND; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; PATIENT COMPLIANCE; TIME FACTORS; TREATMENT OUTCOME; TREATMENT REFUSAL;

EID: 79960918249     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001056     Document Type: Review

References (42)

1. World Health Organization, Joint United Nations Programme on HIV/AIDS, United Nations Children's Fund (2010) Towards universal access: scaling up priority HIV/AIDS interventions in the health sector; progress report 2010 Geneva World Health Organization Available: http://whqlibdoc.who.int/publications/2010/9789241500395_eng.pdf. Accessed 13 June 2011.
2. Fox MP, Rosen S, (2010) Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review. Trop Med Int Health 15 (Suppl 1): 1-15.
3. Brinkhof MW, Dabis F, Myer L, Bangsberg DR, Boulle A, et al. (2008) Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ 86: 559-567.
4. Leisegang R, Cleary S, Hislop M, Davidse A, Regensberg L, et al. (2009) Early and late direct costs in a Southern African antiretroviral treatment programme: a retrospective cohort analysis. PLoS Med 6: e1000189 doi:10.1371/journal.pmed.1000189.
5. Alcorn K, (2010) March 25 South Africa to launch mass HIV testing drive in April, to test 15 million in one year. AIDSMap News, NAM Publications. Available: http://www.aidsmap.com/South-Africa-to-launch-mass-HIV-testing-drive-in-April-to-test-15-million-in-one-year/page/1438260/. Accessed 13 June 2011.
6. Cornell M, Grimsrud A, Fairall L, Fox MP, van Cutsem G, et al. (2010) Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007. AIDS 24: 2263-2270.
7. Keiser O, Anastos K, Schechter M, Balestre E, Myer L, et al. (2008) Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America. Trop Med Int Health 13: 870-879.
8. Geng EH, Nash D, Kambugu A, Zhang Y, Braitstein P, et al. (2010) Retention in care among HIV-infected patients in resource-limited settings: emerging insights and new directions. Curr HIV/AIDS Rep 7: 234-244.
9. Jani I, Sitoe N, Alfai E, Chongo P, Lehe J, et al. (2010) Point-of-care CD4 improves patient retention and time-to-initiation of ART in Mozambique [abstract]. Abstract FRLBE101. XVIII International AIDS Conference; 18-23 July 2010; Vienna, Austria.
10. Faal M, Naidoo N, Makgamatha L, Venter F, Osih R, (2010) Effect of an immediate CD4 result during VCT on patient retention in ART [abstract]. Abstract TUPE0113. XVIII International AIDS Conference; 18-23 July 2010; Vienna, Austria.
11. Mtapuri-Zinyowera S, Chideme M, Mangwanya D, Mugurungi O, Gudukeya S, et al. (2010) Evaluation of the PIMA point-of-care CD4 analyzer in VCT clinics in Zimbabwe. J Acquir Immune Defic Syndr 55: 1-7.
12. Larson BA, Ndibongo B, Brennan A, Bistline K, Xulu T, et al. (2011) Point-of-care CD4 testing after HIV diagnosis to reduce losses to initiation of antiretroviral therapy: an evaluation of a pilot program at the Themba Lethu Clinic, Johannesburg, South Africa [abstract]. South African AIDS Conference; 7-10 June 2011; Durban, South Africa.
13. Larson BA, Bistline K, Ndibongo B, Xulu T, Brennan A, et al. (2011) Rapid point-of-care CD4 testing at mobile HIV testing sites to increase linkage to care: an evaluation of a pilot program in South Africa [abstract]. South African AIDS Conference; 7-10 June 2011; Durban, South Africa.
14. Kohler P, Chung M, Benki-Nugent S, McGrath C, Attwa M, et al. (2011) Free CTX substantially improves retention among ART-ineligible clients in a Kenyan HIV treatment program [abstract]. Abstract 1018. 18th Conference on Retroviruses and Opportunistic Infections; 28 February-3 March 2011; Boston, Massachusetts, United States of America.
15. Fraser HS, Allen C, Bailey C, Douglas G, Shin S, et al. (2007) Information systems for patient follow-up and chronic management of HIV and tuberculosis: a life-saving technology in resource-poor areas. J Med Internet Res 9: e29.
16. Assefa Y, Van D, Mariam DH, Kloos H, (2010) Toward universal access to HIV counseling and testing and antiretroviral treatment in Ethiopia: looking beyond HIV testing and ART initiation. AIDS Patient Care STDS 24: 521-525.
17. Berhanu AL, (2009) Confirmed referral for pre-ART and ART services: best practices from USAID/PSP-Ethiopia mobile HIV counseling and testing [abstract]. Abstract 1462. HIV Implementers Conference; 10-14 June 2009; Windhoek, Namibia.
18. Mulissa Z, Jerene D, Lindtjørn B, (2010) Patients present earlier and survival has improved, but pre-ART attrition is high in a six-year HIV cohort data from Ethiopia. PLoS ONE 5: e13268 doi:10.1371/journal.pone.0013268.
19. Karcher H, Omondi A, Odera J, Kunz A, Harms G, (2007) Risk factors for treatment denial and loss to follow-up in an antiretroviral treatment cohort in Kenya. Trop Med Int Health 12: 687-694.
20. Amolloh M, Medley A, Owuor P, Audi B, Sewe M, et al. (2011) Factors associated with early uptake of HIV care and treatment services after testing HIV+ during home-based testing and counseling in rural Western Kenya [abstract]. Abstract 1077. 18th Conference on Retroviruses and Opportunistic Infections; 28 February-3 March 2011; Boston, Massachusetts, United States of America.
21. Gareta D, Tweya H, Weigel R, Phiri S, Chiwoko J, et al. (2010) Linking HIV-infected pregnant women to antiretroviral therapy: experience from Lilongwe, Malawi [abstract]. Abstract MOPE0277. XVIII International AIDS Conference; 18-23 July 2010; Vienna, Austria.
22. Tayler-Smith K, Zachariah R, Massaquoi M, Manzi M, Pasulani O, et al. (2010) Unacceptable attrition among WHO stages 1 and 2 patients in a hospital-based setting in rural Malawi: can we retain such patients within the general health system? Trans R Soc Trop Med Hyg 104: 313-319.
23. Zachariah R, Harries AD, Manzi M, Gomani P, Teck R, et al. (2006) Acceptance of anti-retroviral therapy among patients infected with HIV and tuberculosis in rural Malawi is low and associated with cost of transport. PLoS ONE 1: e121 doi:10.1371/journal.pone.0000121.
24. Micek M, Gimbel-Sherr K, Baptista AJ, Matediana E, Montoya P, et al. (2009) Loss to follow-up of adults in public HIV care systems in central Mozambique: identifying obstacles to treatment. J Acquir Immune Defic Syndr 52: 397-405.
25. April MD, Walensky RP, Chang Y, Pitt J, Freedberg KA, et al. (2009) Testing rates and outcomes in a South African community, 2001-2006: implications for expanded screening policies. J Acquir Immune Defic Syndr 51: 2001-2006.
26. Bassett IV, Wang B, Chetty S, Mazibuko M, Bearnot B, et al. (2009) Loss to care and death before antiretroviral therapy in Durban, South Africa. J Acquir Immune Defic Syndr 51: 135-139.
27. Bassett IV, Regan S, Chetty S, Giddy J, Uhler LM, et al. (2010) Who starts antiretroviral therapy in Durban, South Africa?...not everyone who should. AIDS 24 (Suppl 1): S37-S44.
28. Ingle SM, May M, Uebel K, Timmerman V, Kotze E, et al. (2010) Outcomes in patients waiting for antiretroviral treatment in the Free State Province, South Africa: prospective linkage study. AIDS 24: 2717-2725.
29. Kaplan R, Orrell C, Zwane E, Bekker LG, Wood R, (2008) Loss to follow-up and mortality among pregnant women referred to a community clinic for antiretroviral treatment. AIDS 22: 1679-1681.
30. Kranzer K, Zeinecker J, Ginsberg P, Orrell C, Kalawe NN, et al. (2010) Linkage to HIV care and antiretroviral therapy in Cape Town, South Africa. PLoS ONE 5: e13801 doi:10.1371/journal.pone.0013801.
31. Larson BA, Brennan A, McNamara L, Long L, Rosen S, et al. (2010) Lost opportunities to complete CD4+ lymphocyte testing among patients who tested positive for HIV in South Africa. Bull World Health Organ 88: 675-680.
32. Larson BA, Brennan A, McNamara L, Long L, Rosen S, et al. (2010) Early loss to follow up after enrolment in pre-ART care at a large public clinic in Johannesburg, South Africa. Trop Med Int Health 15 (Suppl 1): 43-47.
33. Lawn SD, Myer L, Harling G, Orrell C, Bekker LG, et al. (2006) Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation. Clin Infect Dis 43: 770-776.
34. Lessells RJ, Mutevedzi PC, Cooke GS, Newell ML, (2011) Retention in HIV care for individuals not yet eligible for antiretroviral therapy: rural KwaZulu-Natal, South Africa. J Acquir Immune Defic Syndr 56: e79-e86.
35. Losina E, Bassett IV, Giddy J, Chetty S, Regan S, et al. (2010) The "ART" of linkage: pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South Africa. PLoS ONE 5: 8 doi:10.1371/journal.pone.0009538.
36. Luseno W, Wechsberg W, Middlesteadt-Ellerson R, Gumula W, (2008) Linkages and barriers to care for high-risk South African women testing positive for HIV [abstract]. Abstract TUPE0209. XVII International AIDS Conference; 3-8 August 2008; Mexico City, Mexico.
37. Naidoo NP, Faal M, Venter WDF, Osih R, (2010) Patient retention-reasons why patients do or do not come back for care after HIV testing [abstract]. Abstract THPE0798. XVIII International AIDS Conference; 18-23 July 2010; Vienna, Austria.
38. Govindasamy D, van Schaik N, Kranzer K, Mpali M, Thuebus E, et al. (2011) Linkage to HIV care from a mobile testing unit in South Africa by different CD4 count strata [abstract]. Abstract 1076. 18th Conference on Retroviruses and Opportunistic Infections; 28 February-3 March 2011; Boston, Massachusetts, United States of America.
39. Nsigaye R, Wringe A, Roura M, Kalluvya S, Urassa M, et al. (2009) From HIV diagnosis to treatment: evaluation of a referral system to promote and monitor access to antiretroviral therapy in rural Tanzania. J Int AIDS Soc 12: 31.
40. Amuron B, Namara G, Birungi J, Nabiryo C, Levin J, et al. (2009) Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda. BMC Public Health 9: 290.
41. Wanyenze RK, Hahn J, Liechty C, Ragland K, Ronald A, et al. (2011) Linkage to HIV care and survival following inpatient HIV counseling and testing. AIDS Behav 15: 751-760.
42. Geng E, Muyindike W, Glidden D, Bwana M, Yiannoutsos CT, et al. (2011) Failure to initiate ART, loss to follow-up and mortality among HIV-infected patients during the pre-ART period in Uganda: Understanding engagement in care in resource-limited settings [abstract]. Abstract 1017. 18th Conference on Retroviruses and Opportunistic Infections; 28 February-3 March 2011; Boston, Massachusetts, United States of America.